Acarbose

Therapeutic indications

Acarbose is indicated for:

Diabetes mellitus

Population group: both men and women, only adults (18 years old or older)

Acarbose is recommended for the treatment of non-insulin dependent (NIDDM) diabetes mellitus in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

150-600 mg in 3 divided doses daily

Contraindications

Acarbose is contraindicated in the following cases:

Severe renal impairment

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe hepatic impairment

Hepatic failure stage IV

Inflammatory bowel disease, intestinal obstruction

at least one of

Inflammatory bowel disease

Intestinal obstruction

Pregnancy

Breastfeeding

Lactation

< Previous: Overview

Next: Precautions >